Press release - 26/01/2010 MicroTEC Südwest convinces in the second round of the BMBF’s Leading Edge Cluster competition The winners of the second round of the German Federal Ministry of Education and Research’s (BMBF) Leading Edge Cluster competition have now been selected. On 26th January 2010, the chairman of the jury, Prof. Dr. Andreas Barner (spokesperson for the Boehringer Ingelheim GmbH Management Board), and the German Research Minister, Prof. Dr. Annette Schavan, announced in Berlin which of the ten finalists of the highly lucrative Leading Edge Cluster…https://www.gesundheitsindustrie-bw.de/en/article/press-release/microtec-suedwest-convinces-in-the-second-round-of-the-bmbf-s-leading-edge-cluster-competition
Press release - 25/01/2010 Amedrix GmbH - New investment paves the way for own production operations The High-Tech Gründerfonds (HTGF) and Life Science Fonds Esslingen are jointly investing a total of 700,000 EUR in Amedrix GmbH, which was founded in January 2009. The Esslingen-based company develops innovative, acellular medical products based on animal collagen for wound regeneration and the reconstruction of degenerated soft tissue, for example. The new investment means that necessary steps can be taken to gain approval for first medical…https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-new-investment-paves-the-way-for-own-production-operations
Press release - 23/12/2009 Zeiss to look to the future following a slump in the fiscal year 2008/2009 In the fiscal year 2008/2009 (ended 30th September), the Carl Zeiss Group clearly felt the impact of the global economic crisis, particularly in its industrial business. In contrast, results from the company’s Medical Systems, Microscopy and Consumer Optics/Optronics Groups were more positive. These figures were presented at the company’s Annual Press Conference in Stuttgart. https://www.gesundheitsindustrie-bw.de/en/article/press-release/zeiss-to-look-to-the-future-following-a-slump-in-the-fiscal-year-2008-2009
Article - 16/12/2009 BioValley “Science meets Business Day 2009” This year’s presentations at the “Science meets Business Day 2009” once again showed that the exchange between science and the industry in the BioValley works extraordinarily well. The “Science meets Business Day 2009” concluded this year’s BioValley Life Science Week, where researchers from five completely different disciplines and their industrial partners presented their views on what makes the economic location in the area bordered by…https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-science-meets-business-day-2009
Article - 08/12/2009 Karl Stock helps turn ideas into products Karl Stock takes abstract ideas and turns them into useable technological possibilities. The 44-year-old works in what could best be described as the one-man engineering office at the Ulm-based Institute of Laser Technologies in Medicine and Metrology (ILM). In contrast to university institutes, Stock’s work does not simply finish with a “paper” published in a journal. Stock strives to go further and his real work starts where others often stop,…https://www.gesundheitsindustrie-bw.de/en/article/news/karl-stock-helps-turn-ideas-into-products
Press release - 03/12/2009 Knowledge in a new dimension 1000 creative minds from all over the world gathered in Ludwigsburg and Stuttgart (Germany) between 30th November and 3rd December 2009 at the Creativity World Forum. The technology initiatives from Baden-Württemberg, brought together by BIOPRO Baden-Württemberg, served to introduce the participants to the world of high technology. In the virtual technology centre, BIOPRO impressively demonstrated how collaboration between several high…https://www.bio-pro.de/en/information/press-release/knowledge-in-a-new-dimension
Article - 30/11/2009 BioPharMaXX cluster to strengthen the Ulm region BioRegionUlm recently announced the launch of BioPharMaXX at a meeting held in Ummendorf castle (close to Ulm). The acronym refers to a cluster focusing on biotechnology, pharmacy and medical technology that was selected as one of twelve regional clusters in a state-wide contest in Baden-Württemberg in 2008. Company representatives and researchers presented projects to improve the time-consuming and costly protein purification process used in…https://www.gesundheitsindustrie-bw.de/en/article/news/biopharmaxx-cluster-to-strengthen-the-ulm-region
Press release - 17/11/2009 More precise radiation therapy with real-time movement detection The innovative tracking technology designed to increase the precision and efficiency of radiotherapy treatment that was developed by mediri GmbH (Heidelberg), winner of the BMBF’s Medical Technology Innovation Competition in 2006, has now been used for the first time. The technology has been integrated into a specifically developed ultrasound system belonging to the Fraunhofer Institute for Biomedical Technology (IBMT, St. Ingbert). https://www.gesundheitsindustrie-bw.de/en/article/press-release/more-precise-radiation-therapy-with-real-time-movement-detection
Press release - 05/11/2009 Canadian companies to establish contacts with potential Baden-Württemberg partners At a Canadian-German partnering event held on 29th October 2009 in Stuttgart, a number of Canadian and German companies presented themselves to an audience of representatives from industry, business associations and politics. The partnering event was jointly organised by the Canadian Consulate and BIOPRO Baden-Württemberg.https://www.gesundheitsindustrie-bw.de/en/article/press-release/canadian-companies-to-establish-contacts-with-potential-baden-wuerttemberg-partners
Press release - 05/11/2009 Canadian companies to establish contacts with potential Baden-Württemberg partners At a Canadian-German partnering event held on 29th October 2009 in Stuttgart, a number of Canadian and German companies presented themselves to an audience of representatives from industry, business associations and politics. The partnering event was jointly organised by the Canadian Consulate and BIOPRO Baden-Württemberg.https://www.bio-pro.de/en/information/press-release/canadian-companies-to-establish-contacts-with-potential-baden-wuerttemberg-partners
Press release - 27/10/2009 Precision Diagnosis of Brain Tumors: Antibody to Detect Enzyme Defect More than 100 different types of brain tumor are known in medicine. Their exact diagnosis is often difficult, because only tiny amounts of tumor tissue are usually available. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the University of Heidelberg have developed an antibody which is highly specific for the characteristic alteration of an enzyme that is typical of two dangerous types of brain tumor.…https://www.gesundheitsindustrie-bw.de/en/article/press-release/precision-diagnosis-of-brain-tumors-antibody-to-detect-enzyme-defect
Press release - 12/10/2009 "EuroPro+MeD" - a new European Medtech Network has been created - aimed at boosting progress and development Under the working title of "EuroPro+MeD", which stands for European Prosthesis + Medical Devices, BioRegio STERN Management GmbH, Germany, Pôle Technologique de Haute-Champagne, (PTHC) France and the Medical Cluster, Switzerland have signed a strategic partnering agreement to boost joint cross-border cooperation projects between their respective companies and research institutes in the field of medical technology. The partnership was…https://www.gesundheitsindustrie-bw.de/en/article/press-release/europro-med-a-new-european-medtech-network-has-been-created-aimed-at-boosting-progress-and-developme
Press release - 24/09/2009 Call for innovative technologies that address global health concerns The World Health Organization is seeking innovative technologies, in particular medical devices that offer solutions to global health concerns in low- and middle-income countries. The deadline for submission of proposals is January the 31st 2010.https://www.gesundheitsindustrie-bw.de/en/article/press-release/call-for-innovative-technologies-that-address-global-health-concerns
Press release - 22/09/2009 Nanoparticles: researchers to map protein corona The way nanoparticles behave in the human body not only depends on their chemical structure. Of greater importance is the way they interact with biological molecules. Professor Gerd Ulrich Nienhaus at the Karlsruhe Institute of Technology (KIT) has developed new methods that enable the quantitative measurement of these dynamic processes.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanoparticles-researchers-to-map-protein-corona
Press release - 18/09/2009 BioRegio STERN initiates cooperation with French medtech network The STERN BioRegion and Ple Technologique de Haute-Champagne are looking to promote cooperation between French and German companies and research institutes in the medtech and associated sectors. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bioregio-stern-initiates-cooperation-with-french-medtech-network
Press release - 14/07/2009 Amedrix GmbH - Successful cell-free products The cell biologist Dr. Thomas Graeve has founded Amedrix GmbH in Esslingen. In future, the company will develop and produce innovative, cell-free medical products based on animal collagen for the purpose of wound regeneration and the reconstruction of degenerated soft tissue, for example. https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-successful-cell-free-products
Article - 09/07/2009 Innovations for medical technology - the MicroMountains iNNOVATION fORUM The second iNNOVATION fORUM for medical technology, held in Tuttlingen on June 23rd, once again enabled companies to find out about promising product ideas. The MicroMountains Network technology initiative could not have chosen a more suitable location than the city of Tuttlingen, well-known as a “world centre of medical technology”. As the biologisation of medical technology is becoming more and more common, researchers at the NMI in Reutlingen…https://www.gesundheitsindustrie-bw.de/en/article/news/innovations-for-medical-technology-the-micromountains-innovation-forum
Press release - 07/07/2009 Investment in the future: ILM receives funds for the purchase of equipment The Ulm-based Institute for Laser Technologies in Medicine and Metrology (ILM) has received a 335,000 euro injection in 2009 through the German government’s Future Investment Programme (Economic Stimulus Packet II), according to the Baden-Württemberg Minister of Economic Affairs Ernst Pfister. The funds, 75 per cent of which are provided by the German government and 25 per cent by the state of Baden-Württemberg, will be used for the modernisation…https://www.gesundheitsindustrie-bw.de/en/article/press-release/investment-in-the-future-ilm-receives-funds-for-the-purchase-of-equipment
Article - 22/06/2009 Scientists with entrepreneurial spirit Dr. Brigitte Angres and Dr. Helmut Wurst have been thinking about establishing their own company for a long time. The Californian biotech company Clontech, where the two scientists worked for several years, will serve as their model now that the two scientists have found an excellent environment for turning their business idea into reality. This environment is the NMI in Reutlingen.https://www.gesundheitsindustrie-bw.de/en/article/news/scientists-with-entrepreneurial-spirit
Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.biooekonomie-bw.de/en/articles/news/we-would-gladly-finance-more-biotechs
Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.gesundheitsindustrie-bw.de/en/article/news/we-would-gladly-finance-more-biotechs
Article - 27/05/2009 Raimund Hibst brings laser into dental practices Nowadays, in many dental practices drills are no longer used to remove caries – much to the patients’ delight. Such practices have replaced drills with lasers, a virtually painless method, with low noise levels and which does not require a local anaesthetic. This is all thanks to the work of Raimund Hibst, a physicist from the ILM in Ulm who has spent many years turning research findings into health market applications, in cooperation with…https://www.gesundheitsindustrie-bw.de/en/article/news/raimund-hibst-brings-laser-into-dental-practices
Press release - 30/04/2009 Will Ulm surgeons set new standard in bypass surgery? A new computer-assisted navigation system, developed by an interdisciplinary team of researchers and doctors at the University of Ulm over the last three years, makes bypass surgery safer and more precise.https://www.gesundheitsindustrie-bw.de/en/article/press-release/will-ulm-surgeons-set-new-standard-in-bypass-surgery
Article - 27/04/2009 Interaction mechanisms between tumours and blood vessels In recognition of the growing importance of angiogenesis research in the field of oncology the German Research Foundation has established two new research consortia as part of its Angiogenesis research priority programme one project focuses on the mechanisms of vascular differentiation and the second on the interaction between tumour cells and cells of the vascular wall which are prerequisites for tumour growth and metastasis.https://www.gesundheitsindustrie-bw.de/en/article/news/interaction-mechanisms-between-tumours-and-blood-vessels
Press release - 20/04/2009 BVMed Annual Report 2008/09: “Process optimization and drive for quality can succeed through cooperation” The German Medical Technology Association BVMed advocates for process optimization and a drive for quality through stronger cooperations in the healthcare market. Our common aim is to keep our healthcare affordable at a high level of quality for everyone. To do so we need continual process optimization and a stronger quality consciousness in healthcare. This requires the joint efforts of health insurance funds physicians hospitals and medtech…https://www.gesundheitsindustrie-bw.de/en/article/press-release/bvmed-annual-report-2008-09-process-optimization-and-drive-for-quality-can-succeed-through-cooperati